Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Other Genetic Tests Revenue [legacy through Q3 2019] by Year
Other Genetic Tests Revenue ($M) [legacy through Q3 2019] ($M)
Natera Other Genetic Tests Revenue [legacy through Q3 2019]: $12.3M in FY2018, up 7.4% from a year earlier. No newer figure appears in the documents we track.
Where the FY2018 figure comes from
Source: Form 10-K (2019-03-15) ↗
Reported in Form 10-K/10-Q Note — Disaggregated Product Revenue (2016–2019Q3).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Genetic Tests Revenue ($M) [legacy through Q3 2019] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2018 | Dec 31, 2018 | 12.3 | +7.4% | Form 10-K (2019-03-15) ↗ |
| FY2017 | Dec 31, 2017 | 11.4 | -8.1% | Form 10-K (2019-03-15) ↗ |
| FY2016 | Dec 31, 2016 | 12.4 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Other Genetic Tests Revenue [legacy through Q3 2019] ($M), annual FY2016–FY2018 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-legacy-other-genetic
See every metric in the Natera KPI table. Data updated Nov 2, 2026.